30
Participants
Start Date
August 31, 2012
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
Desvenlafaxine
Patients will be initiated on 50 mg/day of Desvenlafaxine. No dose changes will be allowed for the first four weeks. If there is partial or no response after four weeks, dosage will then be increased to 100mg/day, based on tolerability and the Investigator's judgment.
Medical Research Associates, Mississauga
Centre for Addiction and Mental Health, Toronto
Centre for Addiction and Mental Health
OTHER